Expression variation: Its relevance to emergence of chronic disease and to therapy

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Mayburd, Anatoly L ^a  

^a CPA Global   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; ARTIFACT; ATHEROSCLEROSIS; CHRONIC DISEASE; DEPRESSION; DIABETES MELLITUS; DRUG TARGETING; GENE EXPRESSION; GENETIC VARIABILITY; MICROARRAY ANALYSIS; NEOPLASM; OBESITY; RANDOMIZATION; TISSUE SPECIFICITY; VALIDITY; BIOLOGY; DNA MICROARRAY; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMAN; METABOLISM; METHODOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; STATISTICS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CHRONIC DISEASE; COMPUTATIONAL BIOLOGY; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SIGNAL TRANSDUCTION; STOCHASTIC PROCESSES; TREATMENT OUTCOME;

EID: 67650067435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005921     Document Type: Article

References (40)

1. Colin C Pritchard, Li Hsu, Jeffrey Delroow, Peter S Nelson (2001) Project normal: Defining normal variance in mouse gene expression. PNAS vol. 98 no. 23: 13266-13271.
2. Adeline R Whitney, Maximilian Diehn, Stephen J Popper, Ash A Alizadeh, Jennifer C, et al. (2003) Individuality and variation in gene expression patterns in human blood. PNAS vol. 100 no. 4: 1896-1901.
3. Bassett DE, Eisen MB, Boguski MS (1999) Gene expression informatics - it's all in your mine. Nat Genet 21: 51-55.
4. Bar-Even A, Paulsson J, Maheshri N, Carmi M, O'Shea E, Pilpel Y, et al. (2006) Noise in protein expression scales with natural protein abundance. Nat Genet 38: 636-643.
5. Suel GM, Garcia-Ojalvo J, Liberman LM, Elowitz MB (2006) An excitable gene regulatory circuit induces transient cellular differentiation. Nature 440: 545-550.
6. Simpson P (1997) Notch signalling in development: on equivalence groups and asymmetric developmental potential. Curr. Opin. Genet. Dev. 7: 537-542.
7. Prieto C, Rivas MJ, Sánchez JM, López-Fidalgo J, De Las R J (2006) Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes. Bioinformatics 22(9): 1103-1110.
8. Andrew Singleton, Amanda Myers, John Hardy (2004) The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Human Molecular Genetics vol. 13, Review Issue 1: R123-R126.
9. Nicole I Wolf, Erik A Sistermans, Maria Cundall, Grace M Hobson, et al. (2005) Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus - Merzbacher disease. Brain 128(4): 743-751.
10. Magee JA, Abdulkadir SA, Milbrandt J (2003) Haploinsufficiency at the Nkx3.1 locus. A paradigm forstochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 3: 273-283.
11. Seidman JG, Seidman C (2002) Transcription factor haploinsufficiency: when half a loaf is not enough. J. Clin. Invest 109: 451-455.
12. Cook DL, Gerber AN, Tapscott SJ (1998) Modeling stochastic gene expression: implications for haploinsufficiency. Proc. Natl Acad. Sci. USA 95: 15641-15646.
13. Lundgren M, et al. (2000) Transcription factor dosage affects changes in higher order chromatin structure associated with activation of a heterochromatic gene. Cell 103: 733-743.
14. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101(25): 9309-14.
15. Zheng CJ, Han LY, Yap CW, Ji ZL, Cao ZW, et al. (2006) Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics. Pharmacol Rev 58: 259-279.
16. Caricasole A, Bakker A, Copani A, Nicoletti F, Gaviraghi G, Terstappen GC (2005) Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep 25(5-6): 309-27.
17. Farmer A, Korszun A, Owen MJ, Craddock N, Jones L, et al. (2008) Medical disorders in people with recurrent depression. Br J Psychiatry 192(5): 351-5.
18. Lechin F, van der Dijs B (2006) Central nervous system circuitry involved in the hyperinsulinism syndrome. Neuroendocrinology 84(4): 222-34.
19. R. Rosmond Obesity and depression: same disease, different names?. Medical Hypotheses 62, Issue 6: 976-979.
20. Buckingham JC (2006) Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol 147, 1: S258-68.
21. Harris RE (2007) Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem 42: 93-126.
22. Vaiserman AM (2008) Epigenetic engineering and its possible role in anti-aging intervention. Rejuvenation Res Feb 11(1): 39-42.
23. Marja J Willemse, Taku Seriu, Klaudia Hettinger, Elisabetta d'Aniello, Wim CJ, et al. (2002) Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood vol. 99 No. 12: 4386-4393.
24. Stockholm D, Benchaouir R, Picot J, Rameau P, Neildez TMA, et al. (2007) The Origin of Phenotypic Heterogeneity in a Clonal Cell Population In Vitro. PLoS ONE 2(4): e394. doi:10.1371/journal.pone.0000394.
25. Gennadi V Glinsky, Takuya Higashiyama, Anna B Glinskii (2004) Classification of Human Breast Cancer Using Gene Expression Profiling as a Component of the Survival Predictor Algorithm. Clinical Cancer Research 10: 2272-2283.
26. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, et al. (2005) Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 136B(1): 12-25.
27. Florence Allantaz, Damien Chaussabel, Dorothee Stichweh, Lynda Bennett, Windy Allman, et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. The Journal of Experimental Medicine vol. 204 No. 9: 2131-2144.
28. Schulz KR, Danna EA, Krutzik PO, Nolan GP (2007) Single-cell phospho-protein analysis by flow cytometry. Curr Protoc Immunol, Aug; Chapter 8:Unit 8.17.
29. Taylor DL (2007) Past, present, and future of high content screening and the field of cellomics. Methods Mol Biol 356: 3-18.
30. Hainfeld JF, Slatkin DN, Smilowitz HM (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. Sep 21;49(18): N309-15.
31. Mayburd AL, Golovchikova I, Mulshine JL (2008) Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics 24(3): 389-95.
32. Hasan S, Daugelat S, Rao PSS, Schreiber M (2006) Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis. PLoS Comput Biol 2(6): e61.
33. Kumar S, Chaudhary K, Foster JM, Novelli JF, Zhang Y, et al. (2007) Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets. PLoS ONE 2(11): e1189.
34. https://expo.intgen.org/geo/.
35. http://www.intgen.org/expo_scientific_release.cfm.
36. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7307.
37. http://www.itl.nist.gov/div898/handbook/index.htm.
38. http://www.ncbi.nlm.nih.gov/sites/entrez.
39. http://discover.nci.nih.gov/gominer/htgm.jsp.
40. http://www.geneontology.org/amigo/help-front.shtml.